These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11936353)

  • 41. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
    Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapidly destructive Staphylococcus epidermidis endocarditis.
    Zinkernagel AS; Speck RF; Ruef C; Zingg W; Berger-Bachi B; Springer B
    Infection; 2005 Jun; 33(3):148-50. PubMed ID: 15940416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic treatment of infective endocarditis.
    Wilson WR; Geraci JE
    Annu Rev Med; 1983; 34():413-27. PubMed ID: 6344769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staphylococcus lugdunensis endocarditis--the hidden peril of coagulase-negative staphylococcus in blood cultures.
    Seenivasan MH; Yu VL
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):489-91. PubMed ID: 12845551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infective endocarditis and glycopeptides.
    Pittet D; Harding I
    J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vancomycin therapy of bacterial endocarditis.
    Hook EW; Johnson WD
    Am J Med; 1978 Sep; 65(3):411-5. PubMed ID: 152580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute Staphylococcus lugdunensis endocarditis with septic cerebral and pulmonary emboli, showing favorable evolution].
    Rodríguez-Gascón M; Roig P; Montagud JB; Merino J
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):465-7. PubMed ID: 14525715
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of aminoglycosides in the treatment of bacterial endocarditis.
    Graham JC; Gould FK
    J Antimicrob Chemother; 2002 Mar; 49(3):437-44. PubMed ID: 11864943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
    Fadel HJ; Tleyjeh IM; Steckelberg JM; Wilson WR; Baddour LM
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1395-8. PubMed ID: 19705174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of endocarditis by vancomycin.
    Newsom SW
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():79-84. PubMed ID: 6520068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.
    Caputo GM; Archer GL; Calderwood SB; DiNubile MJ; Karchmer AW
    Am J Med; 1987 Oct; 83(4):619-25. PubMed ID: 3674050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New evidence on the use of fosfomycin for bacteremia and infectious endocarditis.
    Veganzones J; Montero A; Maseda E
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):25-29. PubMed ID: 31131589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of glycopeptide antibiotics in the treatment of infective endocarditis.
    Grüneberg RN; Antunes F; Chambers HF; Garau J; Graninger W; Menichetti F; Peetermans WE; Pittet D; Shah PM; Vogelaers D
    Int J Antimicrob Agents; 1999 Aug; 12(3):191-8. PubMed ID: 10461836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Staphylococcus epidermidis infections.
    Lowy FD; Hammer SM
    Ann Intern Med; 1983 Dec; 99(6):834-9. PubMed ID: 6360002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prosthetic valve endocarditis due to highly beta-lactam-resistant
    Tanaka I; Morioka S; Honda A; Miyazaki R; Wajima T; Nakaminami H; Kato T
    Access Microbiol; 2022; 4(11):acmi000437. PubMed ID: 36644435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical treatment of infective endocarditis: general principles.
    Besnier JM; Choutet P
    Eur Heart J; 1995 Apr; 16 Suppl B():72-4. PubMed ID: 7671929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.